Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cell Biology

Background:

• Bone tissue engineering (BTE) offers solutions for bone defects, overcoming limitations of traditional bone grafting.
• Adult mesenchymal stem cells are preferred for BTE over embryonic stem cells due to ethical considerations.
• Bone marrow mesenchymal stem cells (BMSCs) are established but have limitations like low yield and poor function in the elderly.

Purpose of the Study:

• To compare bone marrow mesenchymal stem cells (BMSCs) and adipose-derived stem cells (ASCs) for BTE applications.
• To elucidate the differences in cell yield, surface markers, differentiation potential, and osteogenic capacity between BMSCs and ASCs.
• To provide a comprehensive understanding for selecting optimal cell sources in bone tissue engineering.

Main Methods:

• Literature review comparing studies that simultaneously utilized BMSCs and ASCs.
• Analysis of cell yield, cell surface markers, and multi-lineage differentiation potential.
• Comparative assessment of in vitro osteogenic capacity and in vivo bone regeneration ability.

Main Results:

• Both BMSCs and ASCs demonstrate osteogenic potential in vitro and in vivo.
• Most in vitro studies indicate inferior osteogenesis of ASCs compared to BMSCs.
• In vivo studies present more controversial findings regarding the bone regeneration capacity of ASCs versus BMSCs.

Conclusions:

• Adipose-derived stem cells (ASCs) offer advantages in yield and harvesting over bone marrow mesenchymal stem cells (BMSCs).
• The osteogenic capacity of ASCs requires further investigation, particularly concerning in vivo performance.
• Understanding these differences is critical for advancing cell-based bone tissue engineering therapies.